Oral OT and AVP Effects on Attention to Emotional Faces in Healthy Adults
Official title: Effects of Oromucosal Oxytocin and Arginine Vasopressin on Top-Down and Bottom-Up Attention to Emotional Faces: A Randomized Placebo-Controlled fMRI Study
Run by University of Electronic Science and Technology of China · NCT07838493 · Data updated 2026-11-12
This study tests whether 24 IU of oxytocin or 24 IU of vasopressin, given as an oral spray/lollipop, change how healthy adults pay attention to emotional faces compared with a placebo.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 30 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Electronic Science and Technology of China Academic / other |
| Locations | 1 site (Chengdu, Sichuang) |
| Status | Recruiting |
| Started | September 18, 2026 |
| Main results expected | December 18, 2026 |
| Study ends | December 22, 2026 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT07838493 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Healthy adults without psychiatric or neurological disorders who are eligible for MRI and willing to provide blood samples, with specific menstrual-cycle considerations for naturally cycling females.
✕Probably not a fit
Individuals with psychiatric or neurological conditions or MRI-incompatibilities may not experience a benefit and may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
In a randomized, double-blind design, healthy adults receive oxytocin, vasopressin, or placebo through an oromucosal administration, then complete behavioral tasks and undergo fMRI to study attention to emotional faces and related brain activity. The study also collects baseline and post-treatment mood and personality measures to control for individual differences. Participants have a resting period after administration before imaging, with blood samples taken prior to scanning. The protocol compares top-down and bottom-up attention patterns and neural responses across the three groups.
Why it matters
Potential benefit: If successful, findings could clarify how oromucosal OT and AVP modulate social attention, potentially informing therapies for social cognition in the future.
How similar studies have gone: Previous intranasal OT studies show modulation of social attention; this study investigates whether oromucosal delivery yields similar behavioral effects with distinct neural patterns.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy subjects without past or current psychiatric or neurological disorders * Normal or corrected-to-normal vision * Eligible for MRI scanning and willing to undergo blood sampling and study treatment administration * For naturally cycling female participants, willingness and ability to complete the experimental session within the predefined menstrual-cycle phase, determined using menstrual history and urinary luteinizing hormone (LH) testing * Willing to comply with study requirements regarding alcohol, caffeine, nicotine, medication use, and other pre-session restrictions Exclusion Criteria: * History of head injury or epilepsy or seizure disorders * Current or past major psychiatric, neurological, or serious medical illness that may affect participant safety or study outcomes * Current use of psychoactive medications, hormonal medications, or other medications that may substantially affect central nervous system or neuroendocrine function * Regular smoking or inability to comply with the required nicotine abstinence period before testing * Face recognition impairment or other visual-perceptual impairment that could interfere with performance of the emotional face tasks
Where it's running
-
University of Electronic Science and Technology of China
Chengdu, Sichuang, China Recruiting
Study contacts
- Study coordinator: Dr.
- Email: yaoshuxia@uestc.edu.cn
- Phone: 8618111297596
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chewing and Eating Rate Linked to Weight in Children
This study tests how chewing, eating speed, and ghrelin levels relate to body weight in healthy kids aged 6–11.
-
Remediation of memory impairments using motor encoding and dynamic imagery in Alzheimer’s disease
This trial tests whether combining real action, motor imagery, and dynamic video cues can help memory in people with early Alzheimer’s disease and compares it to a control group without Alzheimer’s.
-
How body composition may affect drug absorption and metabolism
This observational study tests whether body composition influences how drugs are absorbed, distributed, and metabolized in healthy volunteers.
-
Safety and food-effect testing of HSK55879 tablets in healthy adults
This will test whether HSK55879 tablets are safe, well tolerated, and how food affects their absorption in healthy adults aged 18–45.
-
MDMA for short-term reduction of experimentally induced pain in healthy adults
The researchers will test whether single oral doses of MDMA reduce experimentally induced acute pain, hyperalgesia, and allodynia in healthy adult volunteers.
-
Rehabilitative video games to improve balance and confidence in older adults
This program will test whether a rehabilitative video game can improve balance, visual-motor skills, and confidence in people aged 60 and older.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.